Literature DB >> 15993027

Microvessel density does not predict outcome in high grade soft tissue sarcoma.

C C West1, N J Brown, D C Mangham, R J Grimer, M W R Reed.   

Abstract

UNLABELLED: The induction of new blood vessel growth into tumours from a pre-existing vascular bed (angiogenesis) is a characteristic of virtually all malignant tumours studied. Previous studies have demonstrated a consistent correlation between the extent of angiogenesis and disease prognosis for a wide range of carcinomas, but not for sarcomas. AIMS: To investigate the most appropriate method for assessment of microvessel density (MVD) using a cohort of patients with large (>5 cm), deep (intramuscular), high grade soft tissue sarcoma and investigate any relationship between MVD, vascular endothelial growth factor (VEGF) expression and prognosis.
METHODS: Forty-two patients were included in the study. MVD was evaluated in peripheral, central, necrotic and hotspot areas within the tumour by either Chalkley count or total count of immunostained vessels in five high power (x 200) visual fields.
RESULTS: Hot spots of angiogenesis were only present in 33% of specimens. There was a strong correlation p<0.001 between the two methods of quantification with Chalkey method being recommended. VEGF expression evaluated by immunohistochemistry was seen in all but one tumour with strong diffuse cytoplasmic staining within tumour cells, which was not correlated with microvessel density, metastasis or survival. There was a positive correlation between MVD and histological subtype (p<0.01), and primary tumour size and the development of metastasis (p=0.049) but MVD was not predictive of metastasis or overall survival.
CONCLUSIONS: Unlike the majority of previous studies involving various types of carcinoma, there was no correlation between microvessel density and metastasis or survival in a group of patients with large (>5 cm), deep, high grade soft tissue sarcoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993027     DOI: 10.1016/j.ejso.2005.04.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  13 in total

Review 1.  Anatomical and microstructural imaging of angiogenesis.

Authors:  Fabian Kiessling; Daniel Razansky; Frauke Alves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 2.  Targeted therapy in sarcomas other than GIST tumors.

Authors:  Douglas Sborov; James L Chen
Journal:  J Surg Oncol       Date:  2014-10-20       Impact factor: 3.454

3.  CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.

Authors:  Iñigo Espinosa; Badreddin Edris; Cheng-Han Lee; Hong Wei Cheng; C Blake Gilks; Yuzhuo Wang; Kelli D Montgomery; Sushama Varma; Rui Li; Robert J Marinelli; Robert B West; Torsten Nielsen; Andrew H Beck; Matt van de Rijn
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

4.  Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas.

Authors:  Ken Shintani; Akihiko Matsumine; Katsuyuki Kusuzaki; Takao Matsubara; Haruhiko Satonaka; Toru Wakabayashi; Yoko Hoki; Atsumasa Uchida
Journal:  Virchows Arch       Date:  2006-11-14       Impact factor: 4.064

Review 5.  New therapeutic targets in soft tissue sarcoma.

Authors:  Elizabeth G Demicco; Robert G Maki; Dina C Lev; Alexander J Lazar
Journal:  Adv Anat Pathol       Date:  2012-05       Impact factor: 3.875

6.  Targeted therapies in sarcomas: challenging the challenge.

Authors:  Juan Martín Liberal; Laura Lagares-Tena; Miguel Sáinz-Jaspeado; Silvia Mateo-Lozano; Xavier García Del Muro; Oscar M Tirado
Journal:  Sarcoma       Date:  2012-06-03

7.  Continuous representation of tumor microvessel density and detection of angiogenic hotspots in histological whole-slide images.

Authors:  Jakob Nikolas Kather; Alexander Marx; Constantino Carlos Reyes-Aldasoro; Lothar R Schad; Frank Gerrit Zöllner; Cleo-Aron Weis
Journal:  Oncotarget       Date:  2015-08-07

Review 8.  The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.

Authors:  Laura Rocchi; Stefano Caraffi; Roberto Perris; Domenica Mangieri
Journal:  Biosci Rep       Date:  2014-11-04       Impact factor: 3.840

9.  Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.

Authors:  Virginia Di Paolo; Ida Russo; Renata Boldrini; Lucilla Ravà; Marco Pezzullo; Maria Chiara Benedetti; Angela Galardi; Marta Colletti; Rossella Rota; Domenico Orlando; Alessandro Crocoli; Hector Peinado; Giuseppe Maria Milano; Angela Di Giannatale
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

Review 10.  Microenvironmental Targets in Sarcoma.

Authors:  Monika Ehnman; Olle Larsson
Journal:  Front Oncol       Date:  2015-11-04       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.